-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Opinion|Videos|March 25, 2024

Identifying Social Determinants of Health in Cardiovascular Care

Medical experts emphasize the importance of partnering with community leaders to address social determinants of health that act as barriers to care.


Related to this article

Andrew D. Zelenetz, MD, PhD, is the chair of the NCCN B-cell Lymphomas panel.  | Image: LinkedIn
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.